These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 27916725)

  • 21. Apparent diffusion coefficient as a prognostic factor in clival chordoma.
    Oh HC; Hong CK; Lee KS; Cha YJ; Ahn SJ; Suh SH; Park HH
    Sci Rep; 2021 Jan; 11(1):486. PubMed ID: 33436803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Features and Prognostic Factors of Children and Adolescents with Clival Chordomas.
    Zhai Y; Bai J; Gao H; Wang S; Li M; Gui S; Li C; Zhang Y
    World Neurosurg; 2017 Feb; 98():323-328. PubMed ID: 27838423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Factors in Clival Chordomas: An Integrated Analysis of 347 Patients.
    Zou Y; Neale N; Sun J; Yang M; Bai HX; Tang L; Zhang Z; Landi A; Wang Y; Huang RY; Zhang PJ; Li X; Xiao B; Yang L
    World Neurosurg; 2018 Oct; 118():e375-e387. PubMed ID: 29969746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chordoma of the skull base: predictors of tumor recurrence.
    Pallini R; Maira G; Pierconti F; Falchetti ML; Alvino E; Cimino-Reale G; Fernandez E; D'Ambrosio E; Larocca LM
    J Neurosurg; 2003 Apr; 98(4):812-22. PubMed ID: 12691407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Male sex as a risk factor for the clinical course of skull base chordomas.
    Rachinger W; Eigenbrod S; Dützmann S; Simon M; Feigl GC; Kremenevskaja N; Kretzschmar H; Zausinger S; Kreth FW; Thon N; Tonn JC
    J Neurosurg; 2014 Jun; 120(6):1313-20. PubMed ID: 24405075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanded endoscopic endonasal approach for treatment of clival chordomas: early results in 12 patients.
    Dehdashti AR; Karabatsou K; Ganna A; Witterick I; Gentili F
    Neurosurgery; 2008 Aug; 63(2):299-307; discussion 307-9. PubMed ID: 18797360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contemporary management of clival chordomas.
    Campbell RG; Prevedello DM; Ditzel Filho L; Otto BA; Carrau RL
    Curr Opin Otolaryngol Head Neck Surg; 2015 Apr; 23(2):153-61. PubMed ID: 25692630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features and surgical outcomes of patients with skull base chordoma: a retrospective analysis of 238 patients.
    Wang L; Wu Z; Tian K; Wang K; Li D; Ma J; Jia G; Zhang L; Zhang J
    J Neurosurg; 2017 Dec; 127(6):1257-1267. PubMed ID: 28059654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chordomas of the craniocervical junction: follow-up review and prognostic factors.
    Colli B; Al-Mefty O
    J Neurosurg; 2001 Dec; 95(6):933-43. PubMed ID: 11765837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The endoscope-assisted ventral approach compared with open microscope-assisted surgery for clival chordomas.
    Komotar RJ; Starke RM; Raper DM; Anand VK; Schwartz TH
    World Neurosurg; 2011; 76(3-4):318-27; discussion 259-62. PubMed ID: 21986431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of immunohistochemical expression of p53 and the proliferation marker Ki-67 antigen in skull base chordomas: relationships between their expression and prognosis.
    Sakai K; Hongo K; Tanaka Y; Nakayama J
    Brain Tumor Pathol; 2007; 24(2):57-62. PubMed ID: 18095132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skull base chordomas: clinical outcome in a consecutive series of 45 patients with long-term follow-up and evaluation of clinical and biological prognostic factors.
    Boari N; Gagliardi F; Cavalli A; Gemma M; Ferrari L; Riva P; Mortini P
    J Neurosurg; 2016 Aug; 125(2):450-60. PubMed ID: 26745472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas.
    Tzortzidis F; Elahi F; Wright D; Natarajan SK; Sekhar LN
    Neurosurgery; 2006 Aug; 59(2):230-7; discussion 230-7. PubMed ID: 16883163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conventional external radiotherapy in the management of clivus chordomas with overt residual disease.
    Zorlu F; Gürkaynak M; Yildiz F; Oge K; Atahan IL
    Neurol Sci; 2000 Aug; 21(4):203-7. PubMed ID: 11214658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-Cbl and Cbl-b expression in skull base chordomas is associated with tumor progression and poor prognosis.
    Luo P; Wang X; Zhou J; Li L; Jing Z
    Hum Pathol; 2018 Apr; 74():129-134. PubMed ID: 29317233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in Dural Penetration of Clival Chordomas Are Associated with Different Prognosis and Expression of Platelet-Derived Growth Factor Receptor-β.
    Zhai Y; Bai J; Wang S; Du J; Wang J; Li C; Gui S; Zhang Y
    World Neurosurg; 2017 Feb; 98():288-295. PubMed ID: 27506406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chordoma and chondrosarcoma: similar, but quite different, skull base tumors.
    Almefty K; Pravdenkova S; Colli BO; Al-Mefty O; Gokden M
    Cancer; 2007 Dec; 110(11):2457-67. PubMed ID: 17894390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clival chordomas: clinical management, results, and complications in 71 patients.
    Sen C; Triana AI; Berglind N; Godbold J; Shrivastava RK
    J Neurosurg; 2010 Nov; 113(5):1059-71. PubMed ID: 19929198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptotic and proliferative markers in chordomas: a study of 26 tumors.
    Kilgore S; Prayson RA
    Ann Diagn Pathol; 2002 Aug; 6(4):222-8. PubMed ID: 12170453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
    Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
    World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.